Atopic Eczema — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Erythema, oedema/papulation, excoriation, lichenification
EASI evaluates four clinical signs across four body regions (head/neck, trunk, upper limbs, lower limbs): Erythema, oedema/papulation (induration), Excoriation, and Lichenification — each scored 0-3 and weighted by affected BSA in each region. Total EASI ranges 0-72. EASI is the primary outcome measure in most AD clinical trials. Severity bands: clear 0, almost clear 0.1-1.0, mild 1.1-7.0, moderate 7.1-21.0, severe 21.1-50.0, very severe 50.1-72.0. Unlike SCORAD, EASI does not include subjective symptoms (itch, sleep loss). EASI 75 (75% improvement) is the standard primary endpoint in biologic trials for AD.
Reference: BAD 2020 AD Guidelines; HOME Initiative